Understanding osteoporosis aims to boost our bone health

Osteoporosis is a debilitating disease which is a huge burden in this high-technology sedentary world. As Bone Mineral Content (BMC) which symbolizes bone health starts to diminish; the relative risk of osteopenia/ osteoporosis will rise. Therefore osteopenic/ osteoporosis management and treatment is a big rheumatology challenge. National Institute for Health and Care Excellence (NICE) focuses on three important factors includes age, Bone Mineral Density (BMD), and fracture risk factor before starting the treatment of osteoporosis. Recently American Association of Clinical Endocrinologists recommended that younger women who have gone through menopause have to get BMD tested which seems very rational. There is significant heterogeneity in the management and treatment of osteoporosis in our daily practice with different Guidelines like NOGG or NOF. Early screening for recognition and on time managing should be our goal and we would be ensured that individuals who are at risk of osteopenia/ osteoporosis would be treated if necessary prior to its disaster complication “fracture”.